Date published: 2026-1-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

T2R7 Inhibitors

T2R7 is a member of the Taste 2 Receptor family, a group of G protein-coupled receptors (GPCRs) responsible for the detection of bitter compounds. Found predominantly on the surface of taste receptor cells within the taste buds of the tongue, T2R7 contributes to the sensory perception that helps organisms differentiate between safe and harmful substances. The expression of T2R7, like many genes, is subject to intricate regulation at the transcriptional level, where a complex interplay between various intracellular signaling pathways and epigenetic modifications determines the rate and timing of gene transcription. The expression of T2R7 is not static and can be influenced by several internal and external factors, including the cellular environment and exposure to specific chemical compounds. The possibility of chemical compounds inhibiting the expression of T2R7 is an area of interest, given that it could provide insights into the regulation of taste receptor function. Certain chemicals may interact directly with the promoter regions of the DNA that encode for T2R7, leading to changes in gene expression. Histone deacetylase inhibitors like Trichostatin A, for example, can cause chromatin to become more condensed, which would reduce the accessibility of transcription machinery to the T2R7 gene, resulting in decreased expression. On the other hand, DNA methyltransferase inhibitors such as 5-Azacytidine could reduce methylation levels at the T2R7 gene promoter, which is often associated with gene silencing, thereby lowering T2R7 expression. Compounds such as LY294002 and U0126, which inhibit the PI3K and MEK1/2 pathways respectively, could attenuate the downstream signaling required for T2R7 transcription. Additionally, epigenetic modifiers like C646 and JQ1 might decrease T2R7 expression by altering the acetylation and methylation status of histones in proximity to the T2R7 gene, affecting the transcriptional dynamics. It's important to emphasize that while these chemicals have the potential to influence gene expression, their specific effects on T2R7 have not been empirically validated.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A could downregulate T2R7 by inhibiting histone deacetylase activity, leading to a more condensed chromatin state around the T2R7 gene, thereby reducing its transcription.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

By inhibiting DNA methyltransferase, 5-Azacytidine may decrease T2R7 expression through the demethylation of gene promoter regions, enhancing gene silencing mechanisms.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin could inhibit T2R7 expression by suppressing mTOR signaling, which may lead to a decrease in the translational machinery that synthesizes the T2R7 protein.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY 294002 may decrease the expression of T2R7 by inhibiting PI3K, which is crucial for the activation of transcription factors involved in the gene's expression.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD 98059 could inhibit the expression of T2R7 by blocking MEK1/2, which would reduce the activation of ERK pathway and subsequent transcriptional activation of T2R7.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

By inhibiting p38 MAPK, SB 203580 may reduce T2R7 transcription by hindering the response to cellular stress signals that otherwise increase gene expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 could inhibit T2R7 expression by blocking JNK, thereby reducing the phosphorylation and activation of transcription factors that drive T2R7 expression.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Y-27632 could decrease T2R7 expression by inhibiting ROCK, which affects cytoskeletal organization and may influence the mechanical signals that control gene expression.

C646

328968-36-1sc-364452
sc-364452A
10 mg
50 mg
$265.00
$944.00
5
(1)

C646 may inhibit T2R7 expression by targeting p300/CBP histone acetyltransferase, reducing acetylation levels of histones near the T2R7 gene, leading to decreased transcription.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

JQ1 could downregulate T2R7 by inhibiting BET bromodomain proteins, which would result in less efficient transcriptional elongation or initiation at the T2R7 locus.